Previous Page  14 / 17 Next Page
Information
Show Menu
Previous Page 14 / 17 Next Page
Page Background

Page 60

allied

academies

J Clin Exp Tox 2017 | Volume 1 | Issue 2

Toxicology and Pharmacology

November 01-02, 2017 | Toronto, Canada

International Conference on

Purpose:

Heart transplantation is one of the most effective

treatment options for congestive heart failure. Current

organ storage methods can preserve the human heart

for only about four to six hours. The organ donor pool

could be dramatically increased if the preservation time

could be lengthened and hearts stored for weeks or even

months prior to transplantation. This study describes the

performance characteristics of explanted Sprague-Dawley

rat hearts before and after cryopreservation using 10%

dimethylsulphoxide (DMSO) and 30% dimethylformamide

(DMF) in Tyrode solution.

Methods:

A modified Morgan perfusion model was used

for this study. Male Sprague- Dawley (ethical approval

AREC/2009/09/002) hearts were harvested and arrested in

a cold (<10°C) Tyrode solution (pH 7.4) for 5 minutes. The

hearts were mounted on the aorta and vena cava to allow

reperfusion in a doubled walled water jacket at 37 °C for

baseline performance studies. The hearts (n=3) were cooled

to 4, -20, -80 and -196°C (liquid nitrogen), and stored for 6

hours. This study was extended to 48 hours and 7 days at

-196 °C (n=6). Cardiac output (aortic and coronary) and an

electrocardiogram were obtained during baseline studies,

followed by cryopreservation and after thawing at times T0,

10, 20, 40, 60, 120 min, 6, 8, 12 and 24 hours. Reperfused

heartsweremonitored for as longas possible. Ethical approval

(AREC/2009/09/002) for the use of laboratory animals

was obtained from the Tshwane University of Technology,

Ethics Committee and the Animal Ethics committee before

experimental work commenced.

Discussion:

The average heart rate of the Sprague-Dawley

rats reduced from 396 beats/minutes to 184 beats/minutes

after anaesthesia. The average survival time of the hearts

under the experimental conditions were seven hours 32

minutes with an average aortic output at 8 hours of 0.62 ml

and 0.52 ml at 12 hours for DMF and 0.61 ml for 8 hours

and 0.35 ml for DMSO at average survival time of 9 hours

44 minutes. A 100 % recovery after cryopreservation with

DMSO and DMF was achieved after storage for 6 hours, 48

hours and 7 days in liquid nitrogen. DMSO and DMF were

equally effective cryoprotectants in this study.

Conclusion:

It was possible to preserve the hearts outside

the body longer than eight hours as previously studied to

168 hour (7days) at –196°C with 100% recovery using both

DMSO and DMF as cryoprotectant.

e:

jocs_scoj@yahoo.com

Comparative performance of Sprague-Dawley rat hearts using DMSO and DMF as cryoprotectants

Jones Ozokwere, Lynton Hazelhurst, Eugene Olivier

and

Maupi Letsoalo

Tshwane University of Technology, South Africa